thalidomide has been researched along with Anterior Cerebral Circulation Infarction in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "She developed transient ischemic attack after the introduction of lenalidomide plus dexamethasone (Rd) therapy despite no vascular risk factors." | 1.48 | Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome. ( Hashida, H; Hatano, K; Irie, K; Matsumoto, H; Mitsutake, A; Tsukada, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitsutake, A | 1 |
| Matsumoto, H | 1 |
| Hatano, K | 1 |
| Irie, K | 1 |
| Tsukada, N | 1 |
| Hashida, H | 1 |
| Yoon, JS | 1 |
| Lee, JH | 1 |
| Tweedie, D | 1 |
| Mughal, MR | 1 |
| Chigurupati, S | 1 |
| Greig, NH | 1 |
| Mattson, MP | 1 |
2 other studies available for thalidomide and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Topics: Adult; Brain; Brain Infarction; Dexamethasone; Female; Humans; Immunologic Factors; Ischemic Attack, | 2018 |
3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation.
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain Infarction; Cell Death; Cytokines; Dis | 2013 |